-
1
المؤلفون: Naruhito Takenaka, Yasuhiro Shimada, Hideo Baba, Yuh Sakata, Taroh Satoh, Yasuhide Yamada, Kenichi Sugihara, Masahiro Goto, Satoshi Morita, Kei Muro, Hideyuki Mishima, Masahiko Watanabe, Yoshito Komatsu, Tadashi Hirooka, Keiichi Takahashi
المصدر: Glob Health Med
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, Nausea, business.industry, Colorectal cancer, Neutropenia, medicine.disease, Gastroenterology, digestive system diseases, Oxaliplatin, FOLFOX, Fluorouracil, Internal medicine, medicine, Adenocarcinoma, Original Article, medicine.symptom, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dae93fa2786f664a1b3318541c42013
https://doi.org/10.35772/ghm.2020.01050 -
2
المؤلفون: Naohiro Tomita, Jin Teshima, Chihiro Tanaka, Yoshiyuki Sakamoto, Keiichi Takahashi, Tetsuya Kusumoto, Kazuhiro Yoshida, Atsuyuki Maeda, Kenjiro Kotake, Hideo Baba, Narikazu Boku, Junichiro Yamauchi, Naruhito Takenaka, Michio Itabashi, Megumi Ishiguro, Eiji Sunami, Ryota Okude, Michio Okabe, Keisuke Aiba, Kenichi Sugihara, Mitsuyoshi Ota, Satoshi Morita
المصدر: Clinical Colorectal Cancer. 19:22-31.e6
مصطلحات موضوعية: medicine.medical_specialty, Adjuvant chemotherapy, Colorectal cancer, business.industry, Hazard ratio, Gastroenterology, Tegafur/uracil, medicine.disease, Confidence interval, Oxaliplatin, 03 medical and health sciences, 0302 clinical medicine, Superiority Trial, Oncology, 030220 oncology & carcinogenesis, Internal medicine, Clinical endpoint, medicine, 030211 gastroenterology & hepatology, business, medicine.drug
-
3
المؤلفون: Hiroya Taniguchi, Eiji Oki, Takako Eguchi-Nakajima, Satoshi Morita, Hiroaki Nozawa, Naruhito Takenaka, Takayuki Yoshino, Daisuke Ozawa, Kuniaki Shirao
المصدر: ESMO Open
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, overall survival, Trifluridine, folfiri, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, ftd/tpi, Internal medicine, Clinical endpoint, Protocol, Medicine, 030212 general & internal medicine, Tipiracil, business.industry, clinical trial, medicine.disease, Oxaliplatin, Irinotecan, chemistry, 030220 oncology & carcinogenesis, FOLFIRI, tas-102, business, medicine.drug
-
4دورية أكاديمية
المؤلفون: Eiji Sunami, Tetsuya Kusumoto, Mitsuyoshi Ota, Yoshiyuki Sakamoto, Kazuhiro Yoshida, Naohiro Tomita, Atsuyuki Maeda, Jin Teshima, Michio Okabe, Chihiro Tanaka, Junichiro Yamauchi, Michio Itabashi, Kenjiro Kotake, Keiichi Takahashi, Hideo Baba, Narikazu Boku, Keisuke Aiba, Megumi Ishiguro, Satoshi Morita, Naruhito Takenaka
المصدر: Clinical Colorectal Cancer; Mar2020, Vol. 19 Issue 1, p22-31.e6, 16p
-
5
المؤلفون: Kuniaki Shirao, Hiroya Taniguchi, Daisuke Ozawa, Hiroaki Nozawa, Naruhito Takenaka, Satoshi Morita, Takayuki Yoshino, Eiji Oki, Takako Eguchi Nakajima
المصدر: Journal of Clinical Oncology. 36:TPS881-TPS881
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, Trifluridine, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Tipiracil, Chemotherapy, Second line treatment, business.industry, medicine.disease, Oxaliplatin, Irinotecan, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5c8e83593142b2eecf014e205b0c7912
https://doi.org/10.1200/jco.2018.36.4_suppl.tps881